BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21940001)

  • 1. [Prevalence of atrial fibrillation and related factors in hospitalized old patients: ESFINGE study].
    López Soto A; Formiga F; Bosch X; García Alegría J;
    Med Clin (Barc); 2012 Mar; 138(6):231-7. PubMed ID: 21940001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation management, outcomes and predictors of stable disease in daily practice: prospective non-interventional study.
    Bosch RF; Kirch W; Theuer JD; Pittrow D; Kohlhaußen A; Willich SN; Bonnemeier H
    Int J Cardiol; 2013 Aug; 167(3):750-6. PubMed ID: 22475841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation in chronic hemodialysis patients: prevalence, types, predictors, and treatment practices in Greece.
    Tsagalis G; Bakirtzi N; Manios E; Chouliaras I; Papagiannidou P; Stamellou E; Akrivos T; Makris F; Psimenou E; Koutroubas G; Xinos K; Vemmos K
    Artif Organs; 2011 Oct; 35(10):916-22. PubMed ID: 21615429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
    Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
    Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective investigation of hospitalized patients with atrial fibrillation in mainland China.
    Society of Cardiology, Chinese Medical Association
    Chin Med J (Engl); 2004 Dec; 117(12):1763-7. PubMed ID: 15603701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry.
    Chiang CE; Naditch-Brûlé L; Murin J; Goethals M; Inoue H; O'Neill J; Silva-Cardoso J; Zharinov O; Gamra H; Alam S; Ponikowski P; Lewalter T; Rosenqvist M; Steg PG
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):632-9. PubMed ID: 22787011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline characteristics and management of patients with atrial fibrillation/flutter in the emergency department: results of a prospective, multicentre registry in China.
    Zhang H; Yang Y; Zhu J; Shao X; Liu Y; Zhao L; Yu P; Zhang H; He Q; Gu X
    Intern Med J; 2014 Aug; 44(8):742-8. PubMed ID: 24893684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frequency of use of oral vitamin K antagonists in patients with atrial fibrillation and cognitive function disturbances].
    Gorzelak P; Zyzak S; Krewko Ł; Mozdzan M; Broncel M
    Pol Merkur Lekarski; 2014 May; 36(215):302-6. PubMed ID: 24964505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial fibrillation and heart failure: natural history and pharmacological treatment.
    Savelieva I; John Camm A
    Europace; 2004 Sep; 5 Suppl 1():S5-19. PubMed ID: 15450275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical presentation, management, and outcomes in the Indian Heart Rhythm Society-Atrial Fibrillation (IHRS-AF) registry.
    Vora A; Kapoor A; Nair M; Lokhandwala Y; Narsimhan C; Ravikishore AG; Dwivedi SK; Namboodiri N; Hygriv R; Saxena A; Nabar A; Garg S; Bardoloi N; Yadav R; Nambiar A; Pandurangi U; Jhala D; Naik A; Nagmallesh ; Rajagopal S; Selvaraj R; Arora V; Thachil A; Thomas J; Panicker G
    Indian Heart J; 2017; 69(1):43-47. PubMed ID: 28228305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Oliveira MM; Mairesse G; Crijns HJ; Simantirakis E; Atar D; Kirchhof P; Vardas P; Tavazzi L; Maggioni AP
    Europace; 2014 Mar; 16(3):308-19. PubMed ID: 24351881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.
    Pappone C; Augello G; Sala S; Gugliotta F; Vicedomini G; Gulletta S; Paglino G; Mazzone P; Sora N; Greiss I; Santagostino A; LiVolsi L; Pappone N; Radinovic A; Manguso F; Santinelli V
    J Am Coll Cardiol; 2006 Dec; 48(11):2340-7. PubMed ID: 17161267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The change in the atrial fibrillation type as a prognosis marker in a community study: long-term data from AFBAR (Atrial Fibrillation in the BARbanza) study.
    Vidal-Perez R; Otero-Raviña F; Lado-López M; Turrado-Turrado V; Rodríguez-Moldes E; Gómez-Vázquez JL; de Frutos-de Marcos C; de Blas-Abad P; Besada-Gesto R; Gonzalez-Juanatey JR;
    Int J Cardiol; 2013 Oct; 168(3):2146-52. PubMed ID: 23452888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the epidemiological profile of patients with atrial fibrillation and heart failure.
    Fabbri G; Maggioni AP
    Expert Rev Cardiovasc Ther; 2012 Sep; 10(9):1133-40. PubMed ID: 23098149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P; Breithardt G; Camm AJ; Crijns HJ; Kuck KH; Vardas P; Wegscheider K
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study.
    Opolski G; Torbicki A; Kosior DA; Szulc M; Wozakowska-Kaplon B; Kolodziej P; Achremczyk P;
    Chest; 2004 Aug; 126(2):476-86. PubMed ID: 15302734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists: Antithrombotic Agents in Atrial Fibrillation (ATA-AF) survey.
    Berisso MZ; Fabbri G; Gonzini L; Caruso D; Fontanella A; Pellegrini F; Silvestri N; Vincenti A; Mathieu G; Di Pasquale G;
    J Cardiovasc Med (Hagerstown); 2014 Aug; 15(8):626-35. PubMed ID: 24978662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and predisposing conditions for atrial fibrillation in hospitalised patients with hypertension.
    Gorczyca-Michta I; Wożakowska-Kapłon B; Tomasik E
    Kardiol Pol; 2013; 71(4):352-8. PubMed ID: 23788340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.